Group 1 - The recombinant protein concept sector increased by 0.80%, ranking 7th among concept sectors, with 16 stocks rising, including Hotgen Biotech and Zhongyuan Union, both hitting the daily limit [1][2] - The leading gainers in the recombinant protein sector included Huayu Pharmaceutical and Shenzhou Cell, which rose by 18.79% and 16.46% respectively [1][2] - The sector experienced a net inflow of 0.35 billion yuan, with 13 stocks receiving net inflows, and 9 stocks exceeding 10 million yuan in net inflow [2][3] Group 2 - Zhongyuan Union led the net inflow with 1.83 billion yuan, followed by Huayu Pharmaceutical and Hotgen Biotech with net inflows of 1.19 billion yuan and 796.26 million yuan respectively [2][3] - The top stocks by net inflow ratio included Zhongyuan Union at 20.01%, Huayu Pharmaceutical at 12.48%, and Tonghua Dongbao at 9.43% [3][4] - The overall performance of the recombinant protein sector was supported by significant capital inflows, indicating strong investor interest [2][3]
重组蛋白概念涨0.80%,主力资金净流入13股